CompletedNot Applicable

Diagnostic Study of Patients With Stage I Testicular Cancer

United States76 participantsStarted 1999-11-16

Plain-language summary

RATIONALE: Diagnostic procedures may improve a doctor's ability to predict the recurrence of testicular cancer. PURPOSE: Diagnostic trial to detect the risk of recurrent disease in patients who have stage I testicular cancer and who have undergone orchiectomy within the previous 12 weeks.

Who can participate

Age range15 Years – 120 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Clinical stage I nonseminomatous germ cell tumor of the testis * Must have had a radical inguinal orchiectomy with or without retroperitoneal lymph node dissection within prior 12 weeks * AFP and HCG normal or decreasing after orchiectomy at a rate consistent with known half lives * Pathology blocks and radiologic studies available * No metastatic disease on physical exam or chest or abdominal/pelvic CT * No pure seminoma (unless associated with elevated AFP at diagnosis) PATIENT CHARACTERISTICS: Age: * 15 and over Performance status: * Not specified Life expectancy: * Not specified Hematopoietic: * Not specified Hepatic: * Not specified Renal: * Not specified Other: * No prior malignancy including prior primary testicular cancer PRIOR CONCURRENT THERAPY: Biologic therapy: * Not specified Chemotherapy: * No prior chemotherapy Endocrine therapy: * Not specified Radiotherapy: * Not specified Surgery: * See Disease Characteristics

What they're measuring

Evidence of regional or metastatic spread

Timeframe: observed at least annually

Trial details

NCT IDNCT00003800

SponsorEastern Cooperative Oncology Group

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2004-12

View on ClinicalTrials.gov More Testicular Germ Cell Tumor trials